1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,552 | 3,740 | 11.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.05. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND | 879 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 14.05. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 2 | SEC Filings | ||
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| 04.05. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 04.05.2021 | 1.866 | Xetra Newsboard | The following instruments on XETRA do have their first trading 04.05.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 04.05.2021
Aktien
1 NO0010895568 Airthings AS
2 ES0105148003... ► Artikel lesen | |
| 09.03. | NanoViricides reports strong pre-clinical data for COVID-19 drugs | 5 | Seeking Alpha | ||
| 09.03. | NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application | 1.188 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 03.03. | Ovid Therapeutics, KemPharm leads healthcare gainers; Vir Biotechnology, NanoViricides among major losers | 17 | Seeking Alpha | ||
| 02.03. | Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher | 8 | Benzinga.com | ||
| 02.03. | NanoViricides, CHF Solutions leads healthcare gainers; FibroGen, Neuronetics among major losers | 18 | Seeking Alpha | ||
| 02.03. | NanoViricides Reports 'Strong Effectiveness' for COVID Drugs | 11 | The Street | ||
| 02.03. | NNVC Stock: The COVID-19 Drug News That Has NanoViricides Rocketing Today | 10 | InvestorPlace | ||
| 02.03. | The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data | 37 | Benzinga.com | ||
| 02.03. | NanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studies | 16 | Seeking Alpha | ||
| 02.03. | NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application | 731 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine... ► Artikel lesen | |
| 17.02. | NanoViricides reports FQ2 results | 9 | Seeking Alpha | ||
| 17.02. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND | 1.666 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 16.02. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 2 | SEC Filings | ||
| 08.02. | NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-19 | 4 | Benzinga.com | ||
| 08.02. | NanoViricides's anti-coronavirus candidate was well tolerated in animal studies | 4 | Seeking Alpha | ||
| 08.02. | NanoViricides, Inc.: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies | 1.451 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based... ► Artikel lesen | |
| 27.01. | Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan | 979 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / January 27, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based... ► Artikel lesen |
Seite:
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 61,40 | +0,82 % | Pharma-Werte mit Potenzial! CureVac, Cardiol Therapeutics, Formycon, Nanorepro | In Deutschland starben im Jahr 2019 rund 231.000 Menschen an den Folgen einer Krebserkrankung. Wie das Statistische Bundesamt mitteilt, war Krebs damit die Ursache für ein Viertel aller Todesfälle.... ► Artikel lesen | |
| MAGFORCE | 3,870 | -1,53 % | DGAP-News: MagForce AG unterstützt den Welthirntumortag und informiert über verschiedene Patientenveranstaltungen, um das Bewusstsein für eine der tödlichsten Krebserkrankungen zu schärfen | DGAP-News: MagForce AG
/ Schlagwort(e): Sonstiges
MagForce AG unterstützt den Welthirntumortag und informiert über verschiedene Patientenveranstaltungen, um das Bewusstsein für eine der... ► Artikel lesen | |
| NANOGATE | 0,552 | -15,85 % | Hot Stocks heute: Clover Health Investments, Nanogate und windeln.de | Im heutigen Podcast geht es mit Clover Health Investments um einen weiteren Zockerwert, auch Nanogate könnte in diese Ecke einsortiert werden. Außerdem wird die Kursbewegung bei windeln.de unter die... ► Artikel lesen | |
| ONTO INNOVATION | 61,00 | +2,52 % | Onto Innovation (ONTO) Investor Presentation - Slideshow | ||
| ITN NANOVATION | 0,100 | -20,00 % | ItN Nanovation: Gericht eröffnet Insolvenzverfahren | Über das Vermögen der ItN Nanovation AG wurde nun das Insolvenzverfahren eröffnet. Auf Entscheidung des Amtsgerichts in Saarbrücken wurde der bisherige vorläufige Insolvenzverwalter Günter Staab zum... ► Artikel lesen | |
| KOPIN | 6,950 | +1,46 % | Even With Google, Smart Glasses, Kopin Has Downside Risks | ||
| NANOFORM FINLAND | 7,190 | -2,57 % | Share subscriptions based on Nanoform Finland Plc's multiple Stock Option Programs | ||
| VEECO INSTRUMENTS | 20,600 | 0,00 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 12.03.2021 | NEW INSTRUMENT AVAILABLE - 12.03.2021:Das Instrument VEO US9224171002 VEECO INSTRUMENTS DL-,01 EQUITY hat seinen ersten Handelstag am 12.03.2021: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr... ► Artikel lesen | |
| NANOFOCUS | 0,900 | +5,88 % | DGAP-DD: NanoFocus AG (deutsch) | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
22.04.2021 / 16:37
Für den... ► Artikel lesen | |
| STARPHARMA | 1,110 | +6,73 % | Starpharma share price rebounds after receiving Indian approval for COVID-19 product | ||
| OBDUCAT | 0,203 | -2,40 % | Obducat receives order for an EITRE 3 NIL-system from KAUST in Saudi Arabia | ||
| ACACIA RESEARCH | 5,150 | -2,83 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 56,50 | 0,00 % | Hear Ye! Hear Ye! NVE Corporation Opens One Market Door | ||
| ADVANCE NANOTEK | 2,420 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 28.05.2021 | CAPITAL ADJUSTMENT INFORMATION - 28.05.2021:Das Instrument MRI HK0066009694 MTR CORP. LTD EQUITY wird ex Kapitalmassnahme gehandelt am 28.05.2021 The instrument MRI HK0066009694 MTR CORP. LTD EQUITY... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
